sglt2 inhibitors vs glp-1 How Do (Sodium-Glucose Cotransporter 2) and (Glucagon-Like Peptide-1) Receptor Agonists Reduce Cardiovascular Outcomes? Common systemic effects of either

For patients throughout Orange County, alcohol tolerance, appetite changes, side effects, and metabolic health concerns are all important details to review as part of a thoughtful treatment plan

Featured on: What is CJC-1295

The risk of eating disorders comorbid with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis

Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question

A lot of people dont bring up diarrhea on GLP-1 medications because they feel its awkward or think its just part of it. I make a point to ask, because bowel changes can signal dehydration, food triggers, or that the dose is moving too fast